ghk-cu administration Dosage and Protocol: The 30-Day Cycle ghk-cu oral administration bioavailability Repost

What It Targets Our Epithalon + GHK-Cu combination peptides are designed to target: Cellular aging pathways, including telomere attrition, oxidative stress, and circadian disruption in midlife and beyond. Sleep quality and recovery in clients with agerelated melatonin decline, tired but wired evenings, or irregular sleepwake cycles. Visible skin agingfine lines, laxity, dullness, and textural changesthrough enhanced collagen, elastin, and dermal remodeling. Overall biological age markers in clients already investing in nutrition, exercise, stress work, and other Better Med Spa protocols (GLP1s, Tesamorelin, etc.)

Who It Is For

Injectable GHK-Cu has no human trials

BPC 157 Peptides Reduced Scarring and Tissue Regeneration Treated tissues demonstrate superior collagen organization compared to controls